(15056323), A. A. O., (15056326), E. A., (15056329), M. B., (15056332), C. M., (15056335), A. L., (15056338), K. T., . . . (15026901), J. N. M. (2025). Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
Chicago-Zitierstil (17. Ausg.)(15056323), Abdullah A. Osman, et al. Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. 2025.
MLA-Zitierstil (9. Ausg.)(15056323), Abdullah A. Osman, et al. Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. 2025.